The development of zirconia/silica hybrids for the adsorption and controlled release of active pharmaceutical ingredients

被引:18
|
作者
Ciesielczyk, Filip [1 ]
Goscianska, Joanna [2 ]
Zdarta, Jakub [1 ]
Jesionowski, Teofil [1 ]
机构
[1] Poznan Univ Tech, Inst Chem Technol & Engn, Fac Chem Technol, Berdychowo 4, PL-60965 Poznan, Poland
[2] Adam Mickiewicz Univ, Lab Appl Chem, Fac Chem, Umultowska 89b, PL-61614 Poznan, Poland
关键词
Binary oxide materials; Sol-gel route; Active pharmaceutical ingredients; Adsorption; Release ability; PORE-SIZE ANALYSIS; SOL-GEL; OXIDE; NANOPARTICLES; PARACETAMOL; IBUPROFEN; WATER; ZRO2; DYES;
D O I
10.1016/j.colsurfa.2018.02.036
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The study concerns the synthesis and application of a novel type of ZrO2-SiO2 binary oxide system. The material was prepared via a sol-gel route, using zirconium(IV) propoxide and tetraethyl orthosilicate solutions as zirconia and silica precursors, ammonia as a promoter of hydrolysis, and ethanol as a solvent. Different amounts of reactants were used to obtain samples with ZrO2:SiO2 molar ratios of 1:1, 4:1 and 1:4. The synthesized oxide materials were additionally calcined at 1000 degrees C to enable the formation of a crystalline structure. Both uncalcined and calcined samples were comprehensively analyzed in terms of morphology, dispersive parameters, surface composition, crystallinity, presence of characteristic functional groups, and porous structure parameters. The proposed methodology of synthesis led to ZrO2-SiO2 oxide systems with micrometric-sized particles, interesting morphology, controlled content of zirconia and silica, and relatively good porous structure parameters. The key element of the study was an evaluation of the ability of the synthesized materials to adsorb and release selected active pharmaceutical ingredients: ibuprofen and paracetamol. It was shown that sorption capacity and release ability were strongly affected by the porosity of the materials and by the quantity of surface functional groups, which were significantly different in calcined and uncalcined samples. An appropriate mechanism of interaction was proposed.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 50 条
  • [1] Silica based metal scavengers for the purification of pharmaceutical active ingredients
    Beland, Francois
    Michaud, Annie
    Morin, Michel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 722 - 722
  • [2] Core-Shell Composite Hydrogels for Controlled Nanocrystal Formation and Release of Hydrophobic Active Pharmaceutical Ingredients
    Badruddoza, Abu Zayed Md
    Godfrin, P. Douglas
    Myerson, Allan S.
    Trout, Bernhardt L.
    Doyle, Patrick S.
    ADVANCED HEALTHCARE MATERIALS, 2016, 5 (15) : 1960 - 1968
  • [3] Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients
    Gioumouxouzis, Christos, I
    Tzimtzimis, Emmanouil
    Katsamenis, Orestis L.
    Dourou, Anthi
    Markopoulou, Catherine
    Bouropoulos, Nikolaos
    Tzetzis, Dimitrios
    Fatouros, Dimitrios G.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 143
  • [4] Self-assembled sorbitol-derived supramolecular hydrogels for the controlled encapsulation and release of active pharmaceutical ingredients
    Howe, Edward J.
    Okesola, Babatunde O.
    Smith, David K.
    CHEMICAL COMMUNICATIONS, 2015, 51 (35) : 7451 - 7454
  • [5] Process development for active pharmaceutical ingredients following a developmental cascade
    Adler, Carmen
    Brunner, Juerg
    Fichtner, Claudia
    Kueng, Peter
    Levis, Michael K.
    Ruchti, Hans-Rudolf
    Sjoeberg, Anders
    Weber, Beat
    CHIMIA, 2006, 60 (09) : 523 - 529
  • [6] Synthetic Development of Key Intermediates and Active Pharmaceutical Ingredients (APIs)
    Laha, Joydev K.
    Zhou, Jianrong Steve
    SYNTHESIS-STUTTGART, 2024, 56 (04): : III - IV
  • [7] Asymmetric organocatalysis in drug discovery and development for active pharmaceutical ingredients
    Burke, Anthony J.
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (01) : 37 - 46
  • [8] Challenges in the development of hydrate phases as active pharmaceutical ingredients - An example
    Feth, Martin P.
    Nagel, Norbert
    Baumgartner, Bruno
    Broeckelmann, Martin
    Rigal, David
    Otto, Bernhard
    Spitzenberg, Michael
    Schulz, Markus
    Becker, Bernd
    Fischer, Franceska
    Petzoldt, Christine
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 42 (1-2) : 116 - 129
  • [9] Design of new controlled release systems for active ingredients.
    McGinniss, VD
    Risser, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U53 - U53
  • [10] Active Pharmaceutical Ingredients Transportation and Release from Aerogel Particles Processes Modeling
    Lebedev, Igor
    Uvarova, Anastasia
    Mochalova, Maria
    Menshutina, Natalia
    COMPUTATION, 2022, 10 (08)